Results 71 to 80 of about 19,061 (206)

Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study

Basic &Clinical Pharmacology &Toxicology, Volume 138, Issue 1, January 2026.
ABSTRACT Background The involvement and sponsorship of pharmaceutical and medical technology (MedTech) companies in deprescribing and medication optimization activities raise questions about conflicts of interest. We surveyed registrants and attendees of previous International Conferences on Deprescribing to explore views on the acceptability and ...
Katharina Tabea Jungo, Cynthia M. Boyd, Barbara Farrell, Caroline McCarthy   +3 more
wiley   +1 more source

Pharmacoeconomics of HIV-infection

Регуляторные исследования и экспертиза лекарственных средств, 2018
Ever since the first registrations of HIV-infections at the territory of the Russian Federation there was started a great process on arrangement and, subsequently, development of anti-HIV system.
R. I. Yagudina, A. U. Kulikov, V. V. Babiy, E. E. Arinina   +3 more
doaj  

The eyes of the beholder: Perceived barriers to successful drug repurposing

British Journal of Pharmacology, Volume 183, Issue 2, Page 219-233, January 2026.
Despite tremendous advances in new drug development over recent decades, the medical needs of an ever increasing and ageing global population are still significantly unmet. Drug repurposing (DR)—finding new therapeutic uses for existing medicinal substances and products—offers a promising strategy by potentially reducing development time, costs and ...
Zsuzsanna Ida Petykó, Dalma Hosszú, Marcell Csanádi, Kristóf Gyöngyösi, George Dennis Obeng, David Ameyaw, Tamás István Dóczi, Zoltán Kaló, Donald C. Lo, Helene G. van der Meer, Pan Pantziarka, András Inotai   +11 more
wiley   +1 more source

A Claims-Based Algorithm for Identifying Hidradenitis Suppurativa Severity

Clinical Epidemiology
Maria C Schneeweiss,1– 3 Priyanka Anand,1,2 Arash Mostaghimi,2,3 Joan Landon,1,2 Denys Shay,1,4 Olivia MT Davies,2,3 Anusha Mohan Kumar,2,3 Aijing Shang,5 Tanja Tran,6 Robert J Glynn,1,2 Kueiyu Joshua Lin,1,2,7,8 Richard Wyss1,2 1Division of ...
Schneeweiss MC, Anand P, Mostaghimi A, Landon J, Shay D, Davies OMT, Kumar AM, Shang A, Tran T, Glynn RJ, Lin KJ, Wyss R   +11 more
doaj  

Development and validation of the Chinese patient-centered integrated care scale

BMC Health Services Research
Background The healthcare system is currently facing challenges in transitioning to a more integrated, patient-centered care. China has implemented various practical exploration and pilot programs in developing an integrated healthcare service system ...
Yue Yin, Wenqing Gao, Xiujuan Cui, Wenxi Tang   +3 more
doaj   +1 more source

PCV21 PHARMACOECONOMIC ANALYSIS OF SOTALOL LOADING: COMPARISON OF 1-DAY INPATIENT LOADING OF IV SOTLOL COMPARED TO THE STANDARD 3-DAY LOADING PROTOCOL [PDF]

, 2019
Hussain Badani, Bomi Seo, F.W. Peyerl
openalex   +1 more source

Relative Efficacy of Immunomodulatory Monotherapies for Psoriasis of the Scalp: A Network Meta‐Analysis Study

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Recently, the literature has expanded with peer‐reviewed studies on immunomodulatory agents' efficacy on scalp psoriasis—which, in turn, widened knowledge gaps regarding these agents' relative effectiveness. We determined the relative efficacy of immunomodulatory monotherapies for scalp psoriasis.
Aditya K. Gupta, Mary A. Bamimore, Tong Wang, Vincent Piguet, Mesbah Talukder   +4 more
wiley   +1 more source

Risk Assessment for Complex Systems Based on Fuzzy Cognitive Maps: A Case of the Biopharmaceutical Industry

Complexity
Analyzing the supply chain (SC) of biopharmaceutical drugs can be challenging due to their complexity, the existence of a wide variety of risks, and the dynamics of the system.
Hadi Abbasian, Reza Yousefi-Zenouz, Abdollah Amirkhani, Masoud Shirzadeh, Akbar Abdollahiasl, Shekoufeh Nikfar, Mohammadreza Siahi-Shadabad, Abbas Kebriaeezadeh   +7 more
doaj   +1 more source

Fluticasone furoate/Vilanterol 92/22 μg once-a-day vs Beclomethasone dipropionate/Formoterol 100/6 μg b.I.D.: a 12-month comparison of outcomes in mild-to-moderate asthma

Multidisciplinary Respiratory Medicine, 2018
Background Bronchial asthma is an inflammatory disease of the airways. Beclomethasone dipropionate/Formoterol (BDP/F) and Fluticasone furoate/Vilanterol (FF/V) are two of the most effective LABA/ICS combinations for managing persistent bronchial asthma ...
Roberto W. Dal Negro, Luca Bonadiman, Paola Turco   +2 more
doaj   +1 more source

Pharmacoeconomics of prophylactic, empirical, and diagnostic-based antibiotic treatments: Focus on surgical site infection and hospitalized community-acquired pneumonia [PDF]

, 2020
Abdul Khairul Rizki Purba
openalex   +1 more source